Fall

Posted by rob on October 28, 2007 under Uncategorized | Be the First to Comment


From guylaine_b

Medical Articles 10/27

Posted by rob on October 27, 2007 under Uncategorized | Be the First to Comment

TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells.

Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia.

Cosmos

Posted by rob on October 25, 2007 under Uncategorized | Be the First to Comment


From Queenscents

Medical Articles 10/15

Posted by rob on under Uncategorized | Be the First to Comment

Molecular
diagnosis and monitoring in the clinical management of patients with
chronic myelogenous leukemia treated with tyrosine kinase inhibitors.

Combined effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell line K562.

A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Medical Articles 10/20

Posted by rob on October 20, 2007 under Uncategorized | Be the First to Comment

Assessing energy expenditure in cancer patients: a pilot validation of a new wearable device.

Release
of angiopoietin-1 by primary human acute myelogenous leukemia cells is
associated with mutations of nucleophosmin, increased by bone marrow
stromal cells and possibly antagonized by high systemic angiopoietin-2
levels.

Images in clinical medicine. FLT3 Mutation and acute myelogenous leukemia with leukostasis.

Medical Articles 10/16

Posted by rob on October 17, 2007 under Uncategorized | Be the First to Comment

Comparative Proteome Profiling and Functional Analysis of Chronic Myelogenous Leukemia Cell Lines.

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.
[Treatment of acute myelogenous leukemia and strategies to overcome multidrug resistance]
Tyrosine kinase inhibitors for chronic myelogenous leukemia.

Prolonged preleukemic phase of chronic myelogenous leukemia.

Medical Articles 10/13

Posted by rob on October 13, 2007 under Uncategorized | Be the First to Comment

Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells.

Tyrosine kinase inhibitors for chronic myelogenous leukemia.
Identification
of novel post-transcriptional targets of the BCR/ABL oncoprotein by
ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.

Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelae.

Medical Articles 10/10

Posted by rob on October 10, 2007 under Uncategorized | Be the First to Comment

RNA interference-about the reality to be exploited in cancer therapy.

Anti-leukaemic
role of acute GvHD after unrelated haematopoietic stem cell
transplantation in intermediate- to high-risk acute myelogenous
leukaemia.
Antiangiogenic
activity of thalidomide in combination with fludarabine, carboplatin,
and topotecan for high-risk acute myelogenous leukemia.

Environmental
factors of celiac disease: Cytotoxicity of hulled wheat species
Triticum monococcum, T. turgidum ssp. dicoccum and T. aestivum ssp.
spelta.

Medical Articles 10/4

Posted by rob on October 4, 2007 under Uncategorized | Be the First to Comment

Effect of Cellular Quiescence on the Success of Targeted CML Therapy.

The
Multikinase Inhibitor Sorafenib Potentiates TRAIL Lethality in Human
Leukemia Cells in Association with Mcl-1 and cFLIPL Down-regulation.

Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib.

Medical Articles 9/2

Posted by rob on October 3, 2007 under Uncategorized | Be the First to Comment

Increased
risk of acute myelogenous leukemia and multiple myeloma in a historical
cohort of upstream petroleum workers exposed to crude oil.

Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.

Reduced
intensity conditioning for allogeneic hematopoietic stem cell
transplantation in myelodysplastic syndromes and acute myelogenous
leukemia.

Medical Articles 10/1

Posted by rob on October 1, 2007 under Uncategorized | Be the First to Comment

Levels
of Serum and Cerebrospinal Fluid Soluble CD27 in the Diagnosis of
Leptomeningeal Involvement of Hematolymphoid Malignancies.

Active
FKHRL1 overcomes imatinib resistance in chronic myelogenous
leukemia-derived cell lines via the production of tumor necrosis
factor-related apoptosis-inducing ligand.
Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia.

Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches.

home top